Neurocrine Biosciences, Inc. (NBIX)
NASDAQ·Healthcare·Biotechnology
$164.63
+2.77%
Mkt Cap $16.66B
Analyst Ratings
Buy
25
Hold
4
Sell
0
Price Target (89 analysts)
$203.82
Range $165.00 – $230.00
Implied Upside
+23.8%
Consensus $203.82 vs current $164.63